A Phase 1 Study to Investigate SNDX-6352 Alone or in Combination With Durvalumab in Patients With Solid Tumors

FPA150 in Patients With Advanced Solid Tumors

First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, ccRCC and NSCLC

A Study of PLX2853 in Advanced Malignancies.

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Expressing Personalized Tumor Antigens Study

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

A Study Evaluating MM-310 in Patients With Solid Tumors